Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Medicinova Announces New Data And Results Of A Phase 2 Clinical Trial Of Mn 166 Ibudilast In Glioblastoma Presented At The 28th Annual Meeting Of The Society For Neuro Oncology is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 ...
Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova ... today announces the study update and interim analysis results from the Company’s COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast ... Read More
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
We look forward to the full data set and expect to have an end of Phase 2 meeting with the U.S. Food ... For more information on this clinical trial, please visit: www.clinicaltrials.gov NCT06054815. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus